Table 1. Characteristics of study cohort.
| cART naive, GBV-C Positive n = 10 | cART naïve, GBV-C Negative n = 21 | Suppressed GBV-C Positive n = 14 | Suppressed, GBV-C Negative n = 14 | |
| Age | 36 | 40 | 47 | 46 |
| Male | 9 | 12 | 13 | 9 |
| Race | ||||
| White | 9 | 16 | 12 | 13 |
| Black | 1 | 5 | 2 | 1 |
| CD4 cells/mm3 | 599 | 323* | 548 | 520 |
| log10HIV VL | 4.10 | 4.86 | NA | NA |
| log10GBV-C VL | 7.88 | NA | 8.03 | NA |
cART = combination antiretroviral therapy. Suppressed = subject is on cART and has a nondetectable (suppressed) HIV viral load. *p<0.01; p-value for all other comparisons is >0.05.